Abstract
An accurate clinical appraisal of #lymphoedema patients is often a
challenge because the lymphoedema disability scales commonly used in
rehabilitation are not completely suitable to a proper classification of
such subjects. Therefore, the choice of how charging the single
#lymphomatous patient to health public and private insurance systems
worldwide is difficult. In order to address this issue, the authors
defined and propose an evaluation system, called Lymphatic Clinical
Severity Score (LCSS) that, analogously to the #Venous Clinical Severity
Score used in the assessment of venous #chronic diseases, is aimed to
assign the patient to a determinate clinical level. The LCSS score
therefore results a useful parameter in evaluating whether to take in
charge a patient is appropriate and how to do it. The LCSS has been
successfully tested on 185 subjects with primary and secondary
lymphoedema. The LCSS score determination can be repeated at the end of
treatments and can be recalculated in the follow-up allowing a numerical
temporal evaluation of the sickness.
For more articles on BJSTR Journal please click on https://biomedres.us/
For more Biomedical Engineering Articles on BJSTR
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.